Literature DB >> 3516042

Infectious complications in adults with bone marrow transplantation and T-cell depletion of donor marrow. Increased susceptibility to fungal infections.

J D Pirsch, D G Maki.   

Abstract

The infectious complications of bone marrow transplantation were reviewed in 43 adults, 22 of whom received transplants from HLA-matched donors without T-cell depletion and 21 of whom received donor marrow pretreated with the murine anti-T-cell monoclonal antibody CT-2 and complement. Recipients of HLA-mismatched, T-cell-depleted transplants had a higher rate of bacteremia (1.33 compared with 0.64 per patient, p = 0.05) and especially systemic fungal infections (0.92 compared with 0.14 per patient, p less than 0.001) than recipients of transplants from HLA-identical donors without T-cell depletion; two thirds of these infections occurred during the granulocytopenic period early after transplantation. Recipients of HLA-identical but T-cell-depleted transplants also had significantly more systemic fungal infections (0.77 per patient, p less than 0.001). T-cell depletion was associated with delayed engraftment, more prolonged granulocytopenia, and more severe lymphopenia and was shown by stepwise multivariate regression analysis to be the most powerful predictor of systemic fungal infection (r = 0.512, p less than 0.0001). Whereas ex-vivo T-cell depletion may reduce the risk of severe graft-versus-host disease, it may predispose the patient to infection, especially with fungi.

Entities:  

Mesh:

Year:  1986        PMID: 3516042     DOI: 10.7326/0003-4819-104-5-619

Source DB:  PubMed          Journal:  Ann Intern Med        ISSN: 0003-4819            Impact factor:   25.391


  21 in total

Review 1.  Diagnosing fungal infections in immunocompromised hosts.

Authors:  C M Tang; J Cohen
Journal:  J Clin Pathol       Date:  1992-01       Impact factor: 3.411

2.  Bone marrow transplantation as primary treatment of leukemia.

Authors:  M J Bozdech
Journal:  West J Med       Date:  1987-09

Review 3.  Key issues concerning fungistatic versus fungicidal drugs.

Authors:  J R Graybill; D S Burgess; T C Hardin
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1997-01       Impact factor: 3.267

Review 4.  Infection in the bone marrow transplant recipient and role of the microbiology laboratory in clinical transplantation.

Authors:  M T LaRocco; S J Burgert
Journal:  Clin Microbiol Rev       Date:  1997-04       Impact factor: 26.132

5.  Costs of antifungal prophylaxis after bone marrow transplantation. A model comparing oral fluconazole, liposomal amphotericin and oral polyenes as prophylaxis against oropharyngeal infections.

Authors:  A Stewart; R Powles; M Hewetson; J Antrum; C Richardson; J Mehta
Journal:  Pharmacoeconomics       Date:  1995-10       Impact factor: 4.981

Review 6.  Immune reconstitution following bone marrow transplantation.

Authors:  U N Verma; A Mazumder
Journal:  Cancer Immunol Immunother       Date:  1993-11       Impact factor: 6.968

Review 7.  Recent advances in the treatment of graft-versus-host disease.

Authors:  Tsuyoshi Iwasaki
Journal:  Clin Med Res       Date:  2004-11

Review 8.  Epidemiology of digestive tract mycoses in immunocompromised patients--a review.

Authors:  C Farina; F Castelli; G Carosi
Journal:  Eur J Epidemiol       Date:  1990-12       Impact factor: 8.082

9.  Infectious complications after allogeneic bone marrow transplantation with and without T-cell depletion of donor marrow.

Authors:  T Schmeiser; M Wiesneth; D Bunjes; R Arnold; B Hertenstein; W Heit; E Kurrle
Journal:  Infection       Date:  1989 May-Jun       Impact factor: 3.553

10.  Clinical evaluation of a new lipid-based delivery system for intravenous administration of amphotericin B.

Authors:  D Caillot; P Chavanet; O Casasnovas; E Solary; G Zanetta; M Buisson; O Wagner; B Cuisenier; A Bonnin; P Camerlynck
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1992-08       Impact factor: 3.267

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.